Famotidine therapy lowers death, intubation risk in COVID-19 patients
29 Oct 2020
byStephen Padilla
Treatment with famotidine in hospitalized patients with the novel coronavirus disease (COVID-19) may help reduce the risk of death, results of a study have shown. It is also associated with a lower risk of the combined outcome of mortality and intubation, as well as decreased levels of serum markers for those with severe disease.
Famotidine therapy lowers death, intubation risk in COVID-19 patients
29 Oct 2020